This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Stockwatch Business Reporter

The TSX Venture Exchange added 2.08 points to 550.05 Wednesday. David Mitchell's halted capital pool shell, Whiteknight Acquisitions III Inc. (WKA), plans to acquire Delivra Inc. as its qualifying transaction, hopefully by the end of November.

Whiteknight III will roll back 1:3.75, leaving it with 1,370,800 postconsolidated shares, and then issue approximately 32,993,500 postconsolidated shares to the shareholders of Delivra, after which Whiteknight III will change its name to Delivra Corp.

Delivra sells a cream, called LivRelief, for relieving joint or muscle pain caused by inflammation. The product, which the company refers to as Canada's No. 1 selling natural pain relief cream, comes in 50-gram, 100-gram or 240-gram tubes that cost between $20 and $70 on-line or in Wal-Mart, Shoppers Drug Mart and many other outlets. The company has other creams as well for the treatment of varicose veins, burns, skin ulcers and nerve pain associated with shingles and sciatica. Those creams range in price from $12 to $120.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS